Hypertriglyceridemia‐Induced Acute Pancreatitis Associated with Ruxolitinib for Hemophagocytic Lymphohistiocytosis: A Case Report

Sarah Medina, Leslie A Ynalvez, Hyeon-Ju Ryoo Ali, Maria E Cabanillas, Ihab Hamzeh, Salil Kumar, Nicolas Palaskas, Anita Deswal, Shaden Khalaf, Harleen Khatra · 2025

Read Hypertriglyceridemia‐Induced Acute Pancreatitis Associated with Ruxolitinib for Hemophagocytic Lymphohistiocytosis: A Case Report by Sarah Medina, Leslie A Ynalvez, Hyeon-Ju Ryoo Ali, Maria E Cabanillas, Ihab Hamzeh, Salil Kumar, Nicolas Palaskas, Anita Deswal, Shaden Khalaf, Harleen Khatra (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12747063.txt.

Description

Medina and co-authors report a fatal drug complication in a 2025 case paper. A thirty seven year old man with stubborn T cell lymphoma received ruxolitinib for a runaway immune syndrome. The drug is known to disturb blood lipids, with high triglycerides in about fifteen percent of users. His levels spiked, and sharp belly pain with raised pancreatic enzymes pointed to pancreatitis driven by the fat surge.

An insulin infusion treated the crisis, but multiorgan failure followed and the patient died. The authors warn that lipid effects of this drug can turn severe, not merely statistical. Monitoring fat levels during treatment, and acting early, is the practical lesson for teams using it in fragile patients.

Catalog record

CREATORSarah Medina, Leslie A Ynalvez, Hyeon-Ju Ryoo Ali, Maria E Cabanillas, Ihab Hamzeh, Salil Kumar, Nicolas Palaskas, Anita Deswal, Shaden Khalaf, Harleen Khatra
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE12 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12747063

Browse the full library · About the Tower of Babel